MARKET

CSII

CSII

Cardiovascular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

53.61
+1.23
+2.35%
Closed 16:45 01/17 EST
OPEN
52.76
PREV CLOSE
52.38
HIGH
53.71
LOW
52.53
VOLUME
263.56K
TURNOVER
--
52 WEEK HIGH
53.71
52 WEEK LOW
27.23
MARKET CAP
1.89B
P/E (TTM)
-575.8324
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CSII and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CSII News

  • Cardiovascular Systems (CSII) Stock Hits New 52-Week High
  • Zacks.19h ago
  • These stocks soared even as the companies lost money — here’s why that’s not as crazy as it sounds
  • MarketWatch.2d ago
  • These stocks soared even as the companies lost money — here’s why that’s not as crazy as it sounds
  • MarketWatch.2d ago
  • Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Second-Quarter Earnings Conference Call Wednesday, February 5
  • Business Wire.5d ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.07%
Healthcare Equipment & Supplies
+0.29%

Hot Stocks

Name
Price
%Change

About CSII

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
More

Webull offers Cardiovascular Systems Inc (CSII) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.